About
We are a Swiss pharmaceutical group providing solutions in more than 70 countries around the world. TRB's particular expertise lies above all in the production, packaging and therapeutic options relating to hyaluronic acid. TRB CHEMEDICA MEA portfolio includes ophthalmological products as VISMED® – Hyaluronic Acid based eye drops and OSTENIL® – Intraarticular injections to treat post-traumatic and degenerative joint disease, such as osteoarthritis.
Technologies
Outlook
MailChimp SPF
Woo Commerce
Bootstrap Framework
Google Maps
Google Tag Manager
Google Maps (Non Paid Users)
WordPress.org
Mobile Friendly
reCAPTCHA
Keywords
rheumatology
osteoarthritis
hyaluronic acid
dry eye
opthalmology
medical equipment manufacturing
pharmaceutical manufacturing
biotechnology
pharmaceutical products
innovation
joint disease treatment
clinical research
pharmaceutical and medicine manufacturing
ocular surface damage
ocular surface repair
regulatory compliance
gmp certified manufacturing
research & development
product development
joint pain
b2b
swiss manufacturing
arthroscopy
global distribution
biofermentative hyaluronic acid
intra-articular injections
ophthalmology
joint mobility improvement
scientific cooperation programs
tendinopathy
Company Information
-
Employees 1
Location
Dubai, Dubai, United Arab Emirates
